30-dday FRN

Federal Register / Vol. 81, No. 106 / Thursday, June 2, 2016 / Notices
participation will be solely at the
discretion of the Chair, with approval of
the Designated Federal Official.
Registration through the designated
contact for the public comment session
is required.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–13052 Filed 6–1–16; 8:45 am]
BILLING CODE 4165–15–P

Dated: May 26, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2016–12895 Filed 6–1–16; 8:45 am]

Submission for OMB Review; 30-Day
Comment Request; Population
Assessment of Tobacco and Health
(PATH) Study (NIDA)

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institute on Drug Abuse;
Notice of Closed Meeting

National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Institute of Neurological Disorders and
Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: June 12–14, 2016.
Time: 6:00 p.m. to 11:30 a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Alan P. Koretsky, Ph.D.,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders and Stroke, NIH, 35 Convent Drive,
Room GF144, Bethesda, MD 20892, (301)
435–2232, [email protected].
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).

VerDate Sep<11>2014

18:30 Jun 01, 2016

Jkt 238001

35369

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel—
Research Support Services for NIDA AIDS
Program (1209).
Date: June 21, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: May 26, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12894 Filed 6–1–16; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

Frm 00077

Fmt 4703

Sfmt 4703

National Institutes of Health

Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on March 11, 2016,
pages 12913–12914 and allowed 60days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_Submission@
omb.eop.gov or by fax to (202) 395–
6974, Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project,
contact: Dr. Kevin P. Conway, Deputy
Director, Division of Epidemiology,
Services, and Prevention Research,
NIDA, NIH, 6001 Executive Boulevard,
Room 5185, Rockville, MD 20852; or
call non-toll-free number (301) 443–
8755 or Email your request, including
your address to: PATHprojectofficer@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Methodological
Studies for the Population Assessment
of Tobacco and Health (PATH) Study
(NIDA), 0925–0675, expiration date 5/
31/2016—Reinstatement Without
Change—NIDA, NIH, in partnership
SUMMARY:

E:\FR\FM\02JNN1.SGM

02JNN1

35370

Federal Register / Vol. 81, No. 106 / Thursday, June 2, 2016 / Notices

with the Food and Drug Administration
(FDA).
Need and Use of Information
Collection: This is a request to continue
the Population Assessment of Tobacco
and Health (PATH) Study’s conduct of
methodological studies in support of
improvements in the Study’s
approaches for data and biospecimen
collection. The PATH Study is a
national longitudinal cohort study of

tobacco use behavior and health among
the U.S. household population of adults
age 18 and older and youth ages 12 to
17; the Study conducts annual or
biannual interviews and collects
biospecimens from adults and youth to
inform FDA’s regulatory actions under
the Family Smoking Prevention and
Control Act. The methodological studies
under this reinstatement will continue
to enhance the approaches used by the

PATH Study for data and biospecimen
collections to obtain high quality and
useful data; minimize respondent
burden; and achieve and maintain high
response, retention, and follow-up rates.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
annualized burden hours are 29,750.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent

Form name

In-person and telephone surveys ........................................

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
burden hours

Biospecimen collection ........................................................

Adults
Youth
Adults
Youth
Adults
Youth
Adults

5,000
3,500
5,000
3,500
1,000
1,000
1,000

1
1
1
1
1
1
1

90/60
90/60
90/60
90/60
2
2
15/60

7,500
5,250
7,500
5,250
2,000
2,000
250

Total ..............................................................................

........................

20,000

20,000

........................

29,750

Web and smartphone/mobile phone surveys ......................
Focus groups and individual in-depth qualitative interviews

Dated: May 27, 2016.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2016–12994 Filed 6–1–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Number of
respondents

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Behavioral Neuroscience.
Date: June 23–24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

18:30 Jun 01, 2016

Jkt 238001

Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue NW.,
Washington, DC 20036.
Contact Person: Mei Qin, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5213, Bethesda, MD 20892,
[email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR16–052
Fogarty NDC R21.
Date: June 27–28, 2016.
Time: 7:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Academic Industrial Partnership.
Date: June 27, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Informatics.
Date: June 27, 2016.
Time: 8:00 a.m. to 5:00 p.m.

PO 00000

Frm 00078

Fmt 4703

Sfmt 4703

Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Claire E Gutkin, Ph.D.,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106,
MSC 7808, Bethesda, MD 20892, 301–594–
3139, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Macromolecular Structure and Function.
Date: June 27, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: William A Greenberg,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4168,
MSC 7806, Bethesda, MD 20892, (301) 435–
1726, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: ACL Injury, Biomechanics and
Osteoarthritis.
Date: June 27, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Aftab A Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, 301–237–
9931, [email protected].

E:\FR\FM\02JNN1.SGM

02JNN1